CDK9 and cervical carcinoma: In summary, our data support the notion that increased pretreatment tumor levels of caspase-8 and CDK9 predict superior clinical responses in cervical cancer patients treated with definitive CRT plus BT, while higher levels of pCDK9 detection are predictive of an impaired clinical response.